-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.
-
Summary
-
Autolus Therapeutics plc quarterly and annual Amortization of Intangible Assets in USD history and change rate from 31 Dec 2019 to 30 Sep 2025.
- Autolus Therapeutics plc Amortization of Intangible Assets for the quarter ending 30 Sep 2025 was $500,000.
- Autolus Therapeutics plc Amortization of Intangible Assets for the twelve months ending 30 Sep 2025 was $1,247,000.
- Autolus Therapeutics plc annual Amortization of Intangible Assets for 2024 was $162,000.
- Autolus Therapeutics plc annual Amortization of Intangible Assets for 2023 was $0, a 100% decline from 2022.
- Autolus Therapeutics plc annual Amortization of Intangible Assets for 2022 was $65,000, a 28% decline from 2021.